Is Travere Therapeutics, Inc. (TVTX) a Buy, Sell, or Hold?
Travere Therapeutics, Inc.
NASDAQ:TVTX
$57.06 USD
$0.77 (1.37%)
- Volume
- 890.17K
- Average Volume
- 2.52M
- Market Capitalization
- $5.31B
- P/E Ratio
- -116.45
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $60.10
- Year Low
- $15.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
92
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
129
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.79M
TVTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
TVTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-06-22 | G-Gift | 0 | 2026-06-22 |
| Coughlin Timothy | director | 2026-06-12 | M-Exempt | 26.52 | 2026-06-16 |
| Coughlin Timothy | director | 2026-06-12 | S-Sale | 50.0747 | 2026-06-16 |
| Coughlin Timothy | director | 2026-06-12 | M-Exempt | 26.52 | 2026-06-16 |
| Baynes Roy D. | director | 2026-06-12 | M-Exempt | 21.38 | 2026-06-16 |
| Baynes Roy D. | director | 2026-06-12 | S-Sale | 50 | 2026-06-16 |
| Baynes Roy D. | director | 2026-06-12 | M-Exempt | 21.38 | 2026-06-16 |
| Williams Brinkley Ruth | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Williams Brinkley Ruth | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Squarer Ron | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Squarer Ron | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Poole Sandra | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Poole Sandra | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Orwin John A | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Orwin John A | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Meckler Jeffrey A | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Meckler Jeffrey A | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| LYONS GARY A | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| LYONS GARY A | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Coughlin Timothy | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Coughlin Timothy | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Bruhn Suzanne Louise | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Bruhn Suzanne Louise | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Baynes Roy D. | director | 2026-05-19 | A-Award | 0 | 2026-05-21 |
| Baynes Roy D. | director | 2026-05-19 | A-Award | 42.26 | 2026-05-21 |
| Coughlin Timothy | director | 2026-05-15 | S-Sale | 43.49 | 2026-05-19 |
| Baynes Roy D. | director | 2026-05-05 | M-Exempt | 18.27 | 2026-05-06 |
| Baynes Roy D. | director | 2026-05-05 | S-Sale | 46.65 | 2026-05-06 |
| Baynes Roy D. | director | 2026-05-05 | M-Exempt | 18.27 | 2026-05-06 |
| Meckler Jeffrey A | director | 2026-05-04 | M-Exempt | 16.33 | 2026-05-06 |
| Meckler Jeffrey A | director | 2026-05-04 | S-Sale | 45 | 2026-05-06 |
| Meckler Jeffrey A | director | 2026-05-04 | M-Exempt | 16.33 | 2026-05-06 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-05-06 | S-Sale | 43.95 | 2026-05-06 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | M-Exempt | 17.96 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-05 | S-Sale | 46.65 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-06 | S-Sale | 43.95 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | S-Sale | 45 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-05-04 | M-Exempt | 17.96 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | M-Exempt | 22.4 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-05 | S-Sale | 46.65 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-06 | S-Sale | 43.95 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | S-Sale | 45 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | M-Exempt | 22.4 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Inrig Jula | officer: CHIEF MEDICAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-05-05 | S-Sale | 46.65 | 2026-05-06 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-05-06 | S-Sale | 43.95 | 2026-05-06 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | 2026-05-05 | S-Sale | 46.65 | 2026-05-06 |
| Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | 2026-05-06 | S-Sale | 43.95 | 2026-05-06 |
| Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | 2026-05-04 | A-Award | 0 | 2026-05-06 |
| Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | 2026-05-04 | M-Exempt | 0 | 2026-05-06 |
| Baynes Roy D. | director | 2026-05-01 | M-Exempt | 6.82 | 2026-05-04 |
| Baynes Roy D. | director | 2026-05-01 | S-Sale | 44.22 | 2026-05-04 |
| Baynes Roy D. | director | 2026-05-01 | M-Exempt | 6.82 | 2026-05-04 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-04-22 | S-Sale | 39.09 | 2026-04-23 |
| LYONS GARY A | director | 2026-04-14 | M-Exempt | 16.33 | 2026-04-16 |
| LYONS GARY A | director | 2026-04-14 | S-Sale | 41.07 | 2026-04-16 |
| LYONS GARY A | director | 2026-04-14 | M-Exempt | 16.33 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 17.11 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 21.38 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 18.27 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 15.43 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 17.94 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | S-Sale | 41.07 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | S-Sale | 42.12 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 17.11 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 18.27 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 21.38 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 15.43 | 2026-04-16 |
| Baynes Roy D. | director | 2026-04-14 | M-Exempt | 17.94 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 20.46 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 8.93 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 22.4 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | S-Sale | 41.07 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 20.46 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 8.93 | 2026-04-16 |
| Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | 2026-04-14 | M-Exempt | 22.4 | 2026-04-16 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-04-13 | A-Award | 0 | 2026-04-15 |
| Heerma Peter | officer: CHIEF COMMERCIAL OFFICER | 2026-04-14 | S-Sale | 41.9288 | 2026-04-15 |
| ROTE WILLIAM E. | officer: Chief Research Officer | 2026-04-13 | A-Award | 0 | 2026-04-15 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-13 | A-Award | 0 | 2026-04-15 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-15 | S-Sale | 41.01 | 2026-04-15 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-15 | S-Sale | 41.75 | 2026-04-15 |
| Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-15 | S-Sale | 42.66 | 2026-04-15 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-04-14 | M-Exempt | 15.46 | 2026-04-15 |
| REED ELIZABETH E | officer: Chief Legal Officer and GC | 2026-04-14 | M-Exempt | 17.96 | 2026-04-15 |